Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors in Brain Damaged Patients Admitted to Intensive Care Unit

Comparative Interest of Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors at 12 Months in Brain Damaged Patients (Stroke or Head Trauma) Admitted to Intensive Care Unit

Transcranial Doppler is performed daily in Intensive Care Unit in brain damaged patients. For a few years now, the measurement of the photomotor reflex by quantitative Pupillometry has been routinely performed in Intensive Care Units. The objective of this work is to see if Transcranial Doppler recorded parameters and Pupillary parameters are correlated to the neurological prognosis evaluated at 9 months by the Modified Rankin Score (mRS) and the Glasgow Outcome Scale Extended (GOS-E).

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

73

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France
        • CHU Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All brain damaged patients (stroke or head trauma), admitted to Intensive Care Unit since December 1, 2020

Description

Inclusion Criteria:

  • All brain damaged patients (stroke or head trauma)
  • Admitted to Intensive Care Unit since December 1, 2020

Exclusion Criteria:

  • Refusal by the patient or his/her legal representative.
  • Benefiting from legal protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
brain damaged patients

All major brain damaged patients (stroke or head trauma) admitted to reanimation will be included.

In the usual practice, they have a Transcranial Doppler and the measurement of the photomotor reflex by quantitative Pupillometry.

It is planned to collect the simultaneous values of the different parameters during 2,000 measurements.

The data will be collected retrospectively from 01/12/2020, and prospectively from 01/04/2021.

This device measures Mean Systolic Velocity (VMS), Tele-Diastolic Velocity (TDV) and Pulsatility Index (PI),
This device measures the photomotor reflex (basic pupil diameter, percentage of variation, latent and slope of the standard photomotor reflex)
Other Names:
  • AlgiScan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Rankin Score (mRS) (0-5)
Time Frame: Year: 1
Modified Rankin Score (mRS) measures the degree of disability following a stroke in a patient (level 0 for patients with no symptoms to level 5 for patients with major disability and total dependency)..
Year: 1
Glasgow Outcome Scale Extended (GOS-E) (1-8)
Time Frame: Year: 1
Glasgow Outcome Scale Extended (GOS-E) measure the impact of brain injured (minimum at 1 (Dead) and maximum at 8 (Upper Good Recovery).
Year: 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Systolic Velocity (VMS)
Time Frame: At inclusion
Measured by Transcranial Doppler right and left.
At inclusion
Intra-Cranial Pressure (ICP)
Time Frame: At inclusion
Collect on medical file.
At inclusion
Pulsatility Index (PI)
Time Frame: At inclusion
Measured by Transcranial Doppler right and left.
At inclusion
Tele-Diastolic Velocity (TDV)
Time Frame: At inclusion
Measured by Transcranial Doppler right and left.
At inclusion
Basic pupil diameter
Time Frame: At inclusion
Measured by Pupillometry right and left
At inclusion
Percentage of variation of the pupil diameter
Time Frame: At inclusion
Measured by Pupillometry right and left
At inclusion
Latent and slope of the standard photomotor reflex
Time Frame: At inclusion
Measured by Pupillometry right and left
At inclusion
Tissue Partial Oxygen Pressure (PtiO2)
Time Frame: At inclusion
Collect on medical file.
At inclusion
Bispectral Index (BIS)
Time Frame: At inclusion
Collect on medical file. BIS is a reflection of the depth of hypnosis
At inclusion
Richmond Agitation-Sedation Scale (RASS)
Time Frame: At inclusion

Richmond Agitation-Sedation Scale (RASS) is a symmetrical rating, with positive values for agitation and negative values for the level of consciousness around a point 0 corresponding to a calm and awake patient.

Collect on medical file.

At inclusion
Heart rate
Time Frame: At inclusion
Collect on medical file.
At inclusion
Blood pressure
Time Frame: At inclusion
Collect on medical file.
At inclusion
Natremia (mmol/l)
Time Frame: At inclusion
Collect on medical file.
At inclusion
Glycemia (mmol/l)
Time Frame: At inclusion
Collect on medical file.
At inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

July 14, 2021

Study Completion (Actual)

August 14, 2022

Study Registration Dates

First Submitted

April 13, 2021

First Submitted That Met QC Criteria

April 14, 2021

First Posted (Actual)

April 15, 2021

Study Record Updates

Last Update Posted (Actual)

May 1, 2023

Last Update Submitted That Met QC Criteria

April 28, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Damage

Clinical Trials on Transcranial Doppler

Subscribe